IL139637A0 - Mechanical stress induced genes, expression products therefrom, and uses thereof - Google Patents

Mechanical stress induced genes, expression products therefrom, and uses thereof

Info

Publication number
IL139637A0
IL139637A0 IL13963799A IL13963799A IL139637A0 IL 139637 A0 IL139637 A0 IL 139637A0 IL 13963799 A IL13963799 A IL 13963799A IL 13963799 A IL13963799 A IL 13963799A IL 139637 A0 IL139637 A0 IL 139637A0
Authority
IL
Israel
Prior art keywords
expression products
genes
mechanical stress
stress induced
products therefrom
Prior art date
Application number
IL13963799A
Other languages
English (en)
Original Assignee
Quark Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quark Biotech Inc filed Critical Quark Biotech Inc
Publication of IL139637A0 publication Critical patent/IL139637A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
IL13963799A 1998-05-15 1999-05-14 Mechanical stress induced genes, expression products therefrom, and uses thereof IL139637A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8567398P 1998-05-15 1998-05-15
PCT/US1999/011066 WO1999060164A1 (en) 1998-05-15 1999-05-14 Mechanical stress induced genes, expression products therefrom, and uses thereof

Publications (1)

Publication Number Publication Date
IL139637A0 true IL139637A0 (en) 2002-02-10

Family

ID=22193209

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13963799A IL139637A0 (en) 1998-05-15 1999-05-14 Mechanical stress induced genes, expression products therefrom, and uses thereof
IL139637A IL139637A (en) 1998-05-15 2000-11-13 Mechanical stress induced genes, expression products therefrom and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL139637A IL139637A (en) 1998-05-15 2000-11-13 Mechanical stress induced genes, expression products therefrom and uses thereof

Country Status (9)

Country Link
EP (1) EP1082463B1 (xx)
JP (1) JP2002535956A (xx)
AT (1) ATE350486T1 (xx)
AU (1) AU4004699A (xx)
CA (1) CA2332150A1 (xx)
DE (1) DE69934688T2 (xx)
IL (2) IL139637A0 (xx)
WO (1) WO1999060164A1 (xx)
ZA (1) ZA200006613B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020151514A1 (en) * 1998-05-11 2002-10-17 Paz Einat Genes associated with mechanical stress, expression products therefrom, and uses thereof
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US7259253B2 (en) 1999-05-14 2007-08-21 Quark Biotech, Inc. Genes associated with mechanical stress, expression products therefrom, and uses thereof
US6986988B2 (en) 1999-10-06 2006-01-17 Quark Biotech, Inc. Method for enrichment of natural antisense messenger RNA
WO2001025488A2 (en) * 1999-10-06 2001-04-12 Quark Biotech, Inc. Method for enrichment of natural antisense messenger rna
US6468749B1 (en) 2000-03-30 2002-10-22 Quark Biotech, Inc. Sequence-dependent gene sorting techniques
WO2002046753A1 (fr) * 2000-12-06 2002-06-13 Takara Bio Inc. Reseau d'adn fonctionnel
US7067646B2 (en) 2001-03-23 2006-06-27 Dana Farber Cancer Institute Methods and compositions for modulating tumor suppression
US20030191073A1 (en) 2001-11-07 2003-10-09 Challita-Eid Pia M. Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
BE1014949A3 (fr) 2001-08-14 2004-07-06 Probiox Procede de detection de stress oxydant et trousse pour sa mise en oeuvre.
JP4200100B2 (ja) 2001-11-07 2008-12-24 アジェンシス，インコーポレイテッド 癌の処置および検出において有用な１６１ｐ２ｆ１０ｂと称される、核酸および対応タンパク質
AU2004274861A1 (en) * 2003-06-06 2005-03-31 Wyeth Methods and materials for identifying agents which modulate bone remodeling and agents identified thereby
CA2582607C (en) 2004-10-08 2016-07-12 Clinuvel Pharmaceuticals Limited Compositions and methods for inducing melanogenesis in a subject
RU2413735C2 (ru) 2005-03-31 2011-03-10 Эдженсис, Инк. Антитела и родственные молекулы, связывающиеся с белками 161p2f10b
US8350009B2 (en) 2005-03-31 2013-01-08 Agensys, Inc. Antibodies and related molecules that bind to 161P2F10B proteins
WO2007022151A2 (en) 2005-08-15 2007-02-22 Vaxin, Inc. Immunization of avians by administration of non-replicating vectored vaccines
FR2893328B1 (fr) * 2005-11-17 2014-01-31 Lvmh Rech Procede pour depister des marqueurs impliques dans la resistance de keratinocytes a des deformations mecaniques.
ZA200901364B (en) 2006-08-31 2010-06-30 Clinuvel Pharmaceuticals Ltd Method of treatment of photodermatoses
PL2957292T3 (pl) 2008-03-27 2018-04-30 Clinuvel Pharmaceuticals Limited Terapia w przypadku bielactwa nabytego
EA201201120A1 (ru) 2010-02-08 2013-03-29 Эдженсис, Инк. Конъюгаты антитело-лекарственное средство (adc), которые связываются с белками 161p2f10b
EP2487185A1 (en) 2011-02-11 2012-08-15 Clinuvel Pharmaceuticals Limited Hexapeptide with improved activity in the repair of cellular DNA of dermal cells
EP3763385A1 (en) 2011-03-21 2021-01-13 Altimmune Inc. Rapid and prolonged immunologic-therapeutic
WO2013025274A1 (en) 2011-08-12 2013-02-21 Merial Limited Vacuum -assisted preservation of biological products, in particular of vaccines
WO2014012090A1 (en) 2012-07-13 2014-01-16 The Broad Institute, Inc. Molecular sleds comprising a positively-charged amino acid sequence and a molecular cargo and uses thereof
DK3494997T3 (da) 2012-07-25 2019-12-02 Broad Inst Inc Inducerbare dna-bindende proteiner og værktøjer til genomperturbation samt anvendelser deraf
WO2014121104A1 (en) * 2013-01-31 2014-08-07 The Regents Of The University Of California Pooled genetic perturbation effects
US11332719B2 (en) 2013-03-15 2022-05-17 The Broad Institute, Inc. Recombinant virus and preparations thereof
WO2015057671A1 (en) 2013-10-14 2015-04-23 The Broad Institute, Inc. Artificial transcription factors comprising a sliding domain and uses thereof
JP6545084B2 (ja) * 2015-11-11 2019-07-17 株式会社Adeka 潤滑油組成物及びその製造方法
WO2022198126A1 (en) * 2021-03-19 2022-09-22 Washington University Methods for generating mechanically-responsive cells and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9204303A (es) * 1991-07-23 1993-11-01 Rhone Poulenc Rorer Int Factor regulador del crecimiento de osteoclasto.
US5445941A (en) * 1993-06-21 1995-08-29 Eli Lilly And Company Method for screening anti-osteoporosis agents
US5763416A (en) * 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
US5968770A (en) * 1995-02-10 1999-10-19 Millennium Pharmaceuticals, Inc. Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target
US5861249A (en) * 1996-04-23 1999-01-19 Cold Spring Harbor Laboratory Assays and reagents for identifying modulators of cdc25-mediated mitotic activation

Also Published As

Publication number Publication date
EP1082463B1 (en) 2007-01-03
EP1082463A4 (en) 2003-05-21
DE69934688D1 (de) 2007-02-15
EP1082463A1 (en) 2001-03-14
AU4004699A (en) 1999-12-06
ZA200006613B (en) 2002-02-14
IL139637A (en) 2009-09-22
ATE350486T1 (de) 2007-01-15
DE69934688T2 (de) 2007-10-18
CA2332150A1 (en) 1999-11-25
WO1999060164A1 (en) 1999-11-25
JP2002535956A (ja) 2002-10-29

Similar Documents

Publication Publication Date Title
IL139637A0 (en) Mechanical stress induced genes, expression products therefrom, and uses thereof
WO2002040634A3 (en) Expression miniarrays and uses thereof
HUP0401591A2 (hu) Új receptor-nukleinsavak és- polipeptidek
EP1005540A4 (en) IKK-BETA PROTEINS, NUCLEIC ACIDS AND METHODS
EP0837928A4 (en) COMPOSITIONS OF RECOMBINED POXVIRUS-CYTOMEGALOVIRUS AND THEIR USE
EP0831885A4 (en) METHODS OF USING THE CONNECTIVE TISSUE GROWTH FACTOR AS AN INDUCING AGENT
WO2000018899A3 (en) Angiotensin converting enzyme homolog and its use
EP1163515A4 (en) THERAPEUTIC AND DIAGNOSTIC AGENTS FOR DISEASES WITH DISTURBED GLUCOSE TOLERENCE
HUP0301581A2 (hu) Sejteken prezentált peptidek
AU2003259222A1 (en) Method of diagnosing alzheimer's disease
WO1999051186A3 (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
MXPA03010100A (es) Tratamiento de la piel.
WO2001062784A3 (en) Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer
HUP0003684A2 (hu) Alzheimer-kór diagnosztizálására szolgáló vizsgálat
WO2022104136A3 (en) Methods and compositions for tauopathy diagnosis and treatment
WO2002018574A3 (en) Human interleukin-four induced protein
PT831899E (pt) Composições de poxvírus-calicivírus recombinantes e suas utilizações
EP1019092A4 (en) THERAPEUTIC AND DIAGNOSTIC TOOLS FOR POOR CARBOHYDRATE TOLERANCE
ATE527376T1 (de) Pna-sonden, sondensätze, verfahren und kits im zusammenhang mit dem nachweis von candida
WO2003063689A3 (en) Islr gene and its association with osteoarthritis and other bone and cartilage disorders, expression products derived therefrom, and uses thereof
WO2003103597A3 (en) DIAGNOSIS AND TREATMENT OF DIABETES AND INSULIN RESISTANCE
EP1078003A4 (en) PLASMIN INHIBITORS FROM AUSTRALIAN BROWN SNAKE $ i (PSEUDONAJA TEXTIL TEXUS)
WO2003103601A3 (en) DIAGNOSIS AND TREATMENT METHODS FOR DIABETES AND INSULIN RESISTANCE
ATE236250T1 (de) Antisense-sequenzen für die hemmung der expression des adhäsionsmoleküls icam-1
TW200516084A (en) Methods for predicting skin stain formation and for screening agent capable of inhibiting skin stain formation by means of promoted genes in stained regions as an indicator